Japan · Delayed Price · Currency is JPY Mizuho Medy Statistics
Total Valuation
Mizuho Medy has a market cap or net worth of JPY 35.49 billion. The enterprise value is 24.66 billion.
| Market Cap | 35.49B |
| Enterprise Value | 24.66B |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Mizuho Medy has 19.05 million shares outstanding.
| Current Share Class | 19.05M |
| Shares Outstanding | 19.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 28.58% |
| Owned by Institutions (%) | 6.07% |
| Float | 13.12M |
Valuation Ratios
The trailing PE ratio is 10.36.
| PE Ratio | 10.36 |
| Forward PE | n/a |
| PS Ratio | 3.15 |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | 20.86 |
| P/OCF Ratio | 18.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.02, with an EV/FCF ratio of 14.50.
| EV / Earnings | 7.20 |
| EV / Sales | 2.19 |
| EV / EBITDA | 5.02 |
| EV / EBIT | 5.31 |
| EV / FCF | 14.50 |
Financial Position
The company has a current ratio of 7.36
| Current Ratio | 7.36 |
| Quick Ratio | 6.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.01% and return on invested capital (ROIC) is 48.54%.
| Return on Equity (ROE) | 19.01% |
| Return on Assets (ROA) | 13.48% |
| Return on Invested Capital (ROIC) | 48.54% |
| Return on Capital Employed (ROCE) | 23.57% |
| Weighted Average Cost of Capital (WACC) | 6.90% |
| Revenue Per Employee | 60.21M |
| Profits Per Employee | 18.32M |
| Employee Count | 187 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, Mizuho Medy has paid 1.31 billion in taxes.
| Income Tax | 1.31B |
| Effective Tax Rate | 27.67% |
Stock Price Statistics
The stock price has increased by +28.57% in the last 52 weeks. The beta is 0.48, so Mizuho Medy's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +28.57% |
| 50-Day Moving Average | 1,793.84 |
| 200-Day Moving Average | 1,614.36 |
| Relative Strength Index (RSI) | 55.80 |
| Average Volume (20 Days) | 105,040 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mizuho Medy had revenue of JPY 11.26 billion and earned 3.43 billion in profits. Earnings per share was 179.80.
| Revenue | 11.26B |
| Gross Profit | 7.82B |
| Operating Income | 4.65B |
| Pretax Income | 4.74B |
| Net Income | 3.43B |
| EBITDA | 4.91B |
| EBIT | 4.65B |
| Earnings Per Share (EPS) | 179.80 |
Balance Sheet
The company has 10.83 billion in cash and n/a in debt, with a net cash position of 10.83 billion or 568.28 per share.
| Cash & Cash Equivalents | 10.83B |
| Total Debt | n/a |
| Net Cash | 10.83B |
| Net Cash Per Share | 568.28 |
| Equity (Book Value) | 18.68B |
| Book Value Per Share | 980.86 |
| Working Capital | 16.92B |
Cash Flow
In the last 12 months, operating cash flow was 1.96 billion and capital expenditures -255.00 million, giving a free cash flow of 1.70 billion.
| Operating Cash Flow | 1.96B |
| Capital Expenditures | -255.00M |
| Free Cash Flow | 1.70B |
| FCF Per Share | 89.30 |
Margins
Gross margin is 69.44%, with operating and profit margins of 41.27% and 30.42%.
| Gross Margin | 69.44% |
| Operating Margin | 41.27% |
| Pretax Margin | 42.05% |
| Profit Margin | 30.42% |
| EBITDA Margin | 43.63% |
| EBIT Margin | 41.27% |
| FCF Margin | 15.11% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 5.36%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 5.36% |
| Dividend Growth (YoY) | -28.57% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 60.64% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.36% |
| Earnings Yield | 9.65% |
| FCF Yield | 4.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 27, 2024. It was a forward split with a ratio of 2.
| Last Split Date | Jun 27, 2024 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Mizuho Medy has an Altman Z-Score of 7.97 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.97 |
| Piotroski F-Score | 3 |